Nurix Therapeutics, Inc. (NRIX) Financials

NASDAQ Currency in USD Disclaimer

$19.57

south_east -$0.41 (-2.05%)
Day's range
$19.13
Day's range
$19.78

NRIX Income statement / Annual

Last year (2023), Nurix Therapeutics, Inc.'s total revenue was $76.99 M, an increase of 99.31% from the previous year. In 2023, Nurix Therapeutics, Inc.'s net income was -$143.95 M. See Nurix Therapeutics, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 11/30/2023 11/30/2022 11/30/2021 11/30/2020 11/30/2019 11/30/2018
Operating Revenue $76.99 M $38.63 M $29.75 M $17.82 M $31.12 M $37.45 M
Cost of Revenue $189.15 M $10.81 M $6.08 M $66.49 M $45.03 M $40.51 M
Gross Profit -$112.16 M $27.82 M $23.67 M -$48.67 M -$13.91 M -$3.07 M
Gross Profit Ratio -1.46 0.72 0.8 -2.73 -0.45 -0.08
Research and Development Expenses $189.15 M $184.50 M $116.43 M $66.49 M $45.03 M $40.51 M
General & Administrative Expenses $42.90 M $38.00 M $31.20 M $16.31 M $8.33 M $6.67 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $42.90 M $38.00 M $31.20 M $16.31 M $8.33 M $6.67 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $232.05 M $222.49 M $147.64 M $82.80 M $53.35 M $47.19 M
Cost And Expenses $232.05 M $222.49 M $147.64 M $82.80 M $53.35 M $47.19 M
Interest Income $11.12 M $3.51 M $823,000.00 $1.21 M $776,000.00 $818,000.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $13.65 M $10.81 M $6.08 M $2.18 M $2.35 M $2.99 M
EBITDA -$141.41 M -$173.06 M -$111.80 M -$62.80 M -$19.88 M -$6.75 M
EBITDA Ratio -1.84 -4.76 -3.96 -3.65 -0.64 -0.18
Operating Income Ratio -2.01 -4.76 -3.96 -3.65 -0.71 -0.26
Total Other Income/Expenses Net $11.12 M $3.51 M $823,000.00 $1.21 M $776,000.00 $818,000.00
Income Before Tax -$143.95 M -$180.36 M -$117.06 M -$63.78 M -$21.46 M -$8.92 M
Income Before Tax Ratio -1.87 -4.67 -3.93 -3.58 -0.69 -0.24
Income Tax Expense $0.00 -$14.32 M $131,000.00 -$20.54 M $239,000.00 $507,000.00
Net Income -$143.95 M -$166.05 M -$117.19 M -$43.24 M -$21.70 M -$9.43 M
Net Income Ratio -1.87 -4.3 -3.94 -2.43 -0.7 -0.25
EPS -2.65 -3.42 -2.73 -2.76 -0.56 -0.59
EPS Diluted -2.65 -3.42 -2.73 -2.76 -0.56 -0.59
Weighted Average Shares Out $54.34 M $48.61 M $42.90 M $15.67 M $38.85 M $16.11 M
Weighted Average Shares Out Diluted $54.34 M $48.61 M $42.90 M $15.67 M $38.85 M $16.11 M
Link